Claims for Patent: 11,052,126
✉ Email this page to a colleague
Summary for Patent: 11,052,126
Title: | Method of treating diseases |
Abstract: | Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal. |
Inventor(s): | Mamluk; Roni (Mazkeret Batya, IL), Teichman; Sam L. (Oakland, CA) |
Assignee: | Chiasma, Inc. (Needham, MA) |
Application Number: | 16/881,348 |
Patent Claims: |
1. A method of treating acromegaly in a subject, the method comprising: a) orally administering to the subject at least one dosage form comprising octreotide, wherein
the subject is administered an H2-receptor antagonist or an antacid; b) monitoring IGF-1 and clinical symptoms or biochemical and symptomatic response of the subject; and c) if IGF-1 is not normal and clinical symptoms are not controlled or biochemical
and symptomatic response is not maintained, then increasing the total dose of oral octreotide administered to the subject.
2. The method of claim 1, wherein the amount of octreotide in each dosage form is 20 mg. 3. The method of claim 1, wherein the administering of octreotide occurs at least 1 hour before a meal or at least 2 hours after a meal. 4. The method of claim 1, wherein the dosage form comprises an oily suspension which is formulated into a capsule. 5. The method of claim 4, wherein the capsule is enterically coated. 6. The method of claim 1, wherein the administering of octreotide occurs twice daily. 7. The method of claim 6, wherein the subject is dosed in the morning and in the evening, comprising a first and second administration. 8. The method of claim 7, wherein the first administration includes one or two dosage forms and the second administration includes one or two dosage forms. 9. The method of claim 7, wherein the first administration includes one dosage form and the second administration includes one dosage form. 10. The method of claim 7, wherein the first administration includes two dosage forms and the second administration includes one dosage form. 11. The method of claim 7, wherein the first administration includes two dosage forms and the second administration includes two dosage forms. 12. The method of claim 1, wherein one dosage form is administered twice a day. 13. The method of claim 1, wherein two dosage forms are administered twice a day. 14. The method of claim 1, wherein one dosage form is administered once a day and two dosage forms are administered once a day. 15. The method of claim 1, wherein the total amount of octreotide administered per day to the subject is 40 mg, 60 mg, or 80 mg. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.